Literature DB >> 10542931

Computed tomography and magnetic resonance imaging features of olfactory neuroblastoma: an analysis of 22 cases.

D Pickuth1, S H Heywang-Köbrunner, R P Spielmann.   

Abstract

The computed tomography (CT) and magnetic resonance imaging (MRI) studies of 22 patients with a histologically proven olfactory neuroblastoma were retrospectively reviewed. The tumours displayed a variety of imaging characteristics and aggressiveness. The expansile tendency of olfactory neuroblastoma is characterised by bowing of the sinus walls. The destructive aspect is manifested as tumour replacing the turbinates, septum, and sinus walls with extension into contiguous areas. The density/signal and enhancement characteristics are non-specific. Olfactory neuroblastoma should be suspected in all ages following identification of a mass in the superior nasal cavity demonstrating both expansile and destructive growth patterns. The otorhinolaryngologist and the radiologist should be aware of this tumour entity, as early diagnosis appropriately guides therapy and predicts survival.

Entities:  

Mesh:

Year:  1999        PMID: 10542931     DOI: 10.1046/j.1365-2273.1999.00295.x

Source DB:  PubMed          Journal:  Clin Otolaryngol Allied Sci        ISSN: 0307-7772


  17 in total

1.  Salvage Treatment of Local Recurrence in Esthesioneuroblastoma: A Meta-analysis.

Authors:  Mitchell R Gore; Adam M Zanation
Journal:  Skull Base       Date:  2011-01

2.  Transcranial resection of olfactory neuroblastoma.

Authors:  Chih-Chun Wang; Yao-Liang Chen; Yung-Shin Hsu; Shih-Ming Jung; Sheng-Po Hao
Journal:  Skull Base       Date:  2005-08

Review 3.  Retropharyngeal lymph node metastasis from esthesioneuroblastoma: a review of the therapeutic and prognostic implications.

Authors:  L V Zollinger; R H Wiggins; R S Cornelius; C D Phillips
Journal:  AJNR Am J Neuroradiol       Date:  2008-05-22       Impact factor: 3.825

4.  Patterns of regional spread for esthesioneuroblastoma.

Authors:  M C Howell; B F Branstetter; C H Snyderman
Journal:  AJNR Am J Neuroradiol       Date:  2011-02-24       Impact factor: 3.825

5.  Lutetium 177-DOTA-TATE therapy for esthesioneuroblastoma: A case report.

Authors:  Juliano Guerra Sabongi; Mônica Carboni Pereira Gonçalves; Cira Danielle Casado Alves; João Alves; Cristovam Scapulatempo-Neto; Sonia Marta Moriguchi
Journal:  Exp Ther Med       Date:  2016-09-20       Impact factor: 2.447

6.  Olfactory neuroblastoma: A case report.

Authors:  Gonca Hanedan Uslu; Emine Canyilmaz; Ahmet Yasar Zengin; Sevdegul Mungan; Adnan Yoney; Osman Bahadir; Huseyin Gocmez
Journal:  Oncol Lett       Date:  2015-10-20       Impact factor: 2.967

7.  Olfactory neuroblastoma: a single-center experience.

Authors:  Marton König; Terje Osnes; Peter Jebsen; Jan Folkvard Evensen; Torstein R Meling
Journal:  Neurosurg Rev       Date:  2017-05-25       Impact factor: 3.042

8.  Intranasal Esthesioneuroblastoma: CT Patterns Aid in Preventing Routine Nasal Polypectomy.

Authors:  M E Peckham; R H Wiggins; R R Orlandi; Y Anzai; W Finke; H R Harnsberger
Journal:  AJNR Am J Neuroradiol       Date:  2017-12-07       Impact factor: 3.825

Review 9.  Esthesioneuroblastoma: Multimodal management and review of literature.

Authors:  Ritesh Kumar
Journal:  World J Clin Cases       Date:  2015-09-16       Impact factor: 1.337

10.  Hyperostotic esthesioneuroblastoma: rare variant and fibrous dysplasia mimicker.

Authors:  Manzoor Ahmed; Phillip Daniel Knott
Journal:  Korean J Radiol       Date:  2014-01-08       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.